<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/wp-content/plugins/xml-sitemap-feed/assets/sitemap-news.xsl?ver=5.7.7"?>
<!-- generated-on="2026-09-10T12:35:43+00:00" -->
<!-- generator="XML Sitemap & Google News for WordPress" -->
<!-- generator-url="https://status301.net/wordpress-plugins/xml-sitemap-feed/" -->
<!-- generator-version="5.7.7" -->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" >
<url><loc>https://acuity.news/regulation/direct-support-professional-dsp-workforce-crisis-medicaid-2026/</loc><news:news><news:publication><news:name>Acuity News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-10T06:33:59-06:00</news:publication_date><news:title>The Workforce That Autism and Disability Services Depend On Is Collapsing, and Almost No One Outside the Field Has Noticed. Direct Support Professionals Are Leaving Faster Than They Can Be Replaced.</news:title></news:news></url>
<url><loc>https://acuity.news/regulation/camber-health-medicaid-lobbying-mcdermott-termination-2026/</loc><news:news><news:publication><news:name>Acuity News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-09T11:21:00-06:00</news:publication_date><news:title>Camber Health’s Federal Medicaid Lobbying Registration Ended August 31 When McDermott+ Closed Its Lobbying Practice. Filings Show $100,000 Spent on Medicaid Fraud and Reimbursement.</news:title></news:news></url>
<url><loc>https://acuity.news/technology/aba-intake-automation-carelu-ai-conversion-eligibility-2026/</loc><news:news><news:publication><news:name>Acuity News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-09T07:31:43-06:00</news:publication_date><news:title>ABA Intake Automation Found Its Market by Accident: Carelu Was Built to Qualify Sales Leads for Contractors, Then a Cold LinkedIn Message Pointed It Toward Autism Care.</news:title></news:news></url>
<url><loc>https://acuity.news/technology/wave-neuroscience-mert-fda-clearance-adult-ptsd-cpt-code-2026/</loc><news:news><news:publication><news:name>Acuity News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-08T11:55:00-06:00</news:publication_date><news:title>Wave Neuroscience’s MeRT Gains FDA Clearance for Adult PTSD on the First Sham-Controlled Trial in the Category. The 510(k) Summary Details the Trial Results, the Safety Profile, and the Reimbursement Path Ahead.</news:title></news:news></url>
<url><loc>https://acuity.news/regulation/iacc-2026-2028-autism-strategic-plan-profound-autism-nih-funding/</loc><news:news><news:publication><news:name>Acuity News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-08T06:53:31-06:00</news:publication_date><news:title>IACC Adopts 2026-2028 Autism Strategic Plan With a $747.4 Million Funding Recommendation. NIH Named Profound Autism a Highlighted Funding Topic the Same Morning, and HRSA Filed 41 Corrections.</news:title></news:news></url>
</urlset>
